Clinical Baseline Factors Predict Response to Natalizumab: Their Usefulness in Patient Selection
BMC Neurology - United Kingdom
doi 10.1186/1471-2377-14-103
Full Text
Open PDFAbstract
Available in full text
Date
May 12, 2014
Authors
Publisher
Springer Science and Business Media LLC